Symbols

CRL

Charles River Laboratories International·NYSE

--(--)

CRL fundamentals

Charles River Laboratories International (CRL) Revenue Breakdown: Q3 2025 Business & Regional Performance
Charles River Laboratories International (CRL) reported total revenue of 1.00B USD in Q3 2025, with its core business segment Research Models and Services contributing 21.24%. Regionally, United States remained the largest market, accounting for 53.50% of total revenue. Explore Charles River Laboratories International's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.

By Business

No Data

By Region

No Data

You can ask Aime

Did Charles River Laboratories International beat or miss consensus estimates last quarter?

What factors drove the changes in Charles River Laboratories International's revenue and profit?

What guidance did Charles River Laboratories International's management provide for the next earnings period?

What does Charles River Laboratories International do and what are its main business segments?

What is Charles River Laboratories International's latest dividend and current dividend yield?

What is the revenue and EPS growth rate for Charles River Laboratories International year over year?

What is the market's earnings forecast for Charles River Laboratories International next quarter?

What were the key takeaways from Charles River Laboratories International's earnings call?